Technology Press Releases
SEE OTHER BRANDS

Get your fresh news on technology in the world

Technology Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Press Releases.

Press releases published on April 28, 2025

Travelution Launches Hotel Booking Platform – 2.6 Million Ways to Wake Up Somewhere Wonderful

Travelution Launches Hotel Booking Platform – 2.6 Million Ways to Wake Up Somewhere Wonderful

Redefining how the world travels – one booking at a time. DUBAI, UNITED ARAB EMIRATES, April 28, 2025 /⁨EINPresswire.com⁩/ -- The journey toward creating the most complete travel ecosystem has taken another major step forward. Travelution is proud to …

Eagle Technischer Workshop in Deutschland

Eagle Technischer Workshop in Deutschland

Technischer Workshop von Eagle am 14.–15. Mai in Schlierbach: Faserlaser, Automatisierung live erleben …

Apple Accessories Market to Reach USD 59,258.0 Million by 2035, Growing at a 7.9% CAGR

Apple Accessories Market to Reach USD 59,258.0 Million by 2035, Growing at a 7.9% CAGR

The Apple Accessories market is growing with increasing demand for innovative, premium products like cases, chargers, …

Nextrend Unveils SAT-10 Cordless Robotic Pool Cleaner with Enhanced Runtime and Smart Navigation

Nextrend Unveils SAT-10 Cordless Robotic Pool Cleaner with Enhanced Runtime and Smart Navigation

Nextrend Launches Cordless Robotic Pool Cleaners with Advanced Automation for Residential and Commercial Use. HOUSTON, TX, UNITED STATES, April 28, 2025 /⁨EINPresswire.com⁩/ -- Nextrend today announced the launch of its SAT-10 cordless robotic pool …

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares

WEST ORANGE, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- BEL FUSE INC. (NASDAQ:BELFA) and (NASDAQ:BELFB) today announced that its Board of Directors has declared regular quarterly cash dividends of $0.06 per share on the Company's Class A common shares and $0 …

Significant Paper Published in JAMA on the Effect of Transcranial Pulsed Current Stimulation

Significant Paper Published in JAMA on the Effect of Transcranial Pulsed Current Stimulation

SINGAPORE, April 28, 2025 /⁨EINPresswire.com⁩/ -- Singapore-based AscenZion Neuromodulation Co announced the publication of a significant paper on the ‘Effect of transcranial pulsed current stimulation on social functioning in children with autism’ in JAMA …

ONMA Scout präsentiert neue Social-Media-Marketing-Lösungen in Hamburg

ONMA Scout präsentiert neue Social-Media-Marketing-Lösungen in Hamburg

GERMANY, April 28, 2025 /⁨EINPresswire.com⁩/ -- ONMA Scout, führender Innovator im digitalen Marketing, hat eine neue Reihe von Social-Media-Marketing-Lösungen vorgestellt, die Unternehmen jeder Größe in Hamburg und ganz Deutschland unterstützen. Die …

Vistatec Recognized with Two TITAN Awards for Excellence in Business and Leadership

Vistatec Recognized with Two TITAN Awards for Excellence in Business and Leadership

DUBLIN, IE-D, IRELAND, April 28, 2025 /⁨EINPresswire.com⁩/ -- Vistatec has been awarded two TITAN Awards for achievements in Marketing and Human Resources at the 2025 TITAN Awards. At the TITAN Business Awards, Vistatec was honored with a Gold award for …

Future Food Asia announces 10 groundbreaking AgriFoodTech startup finalists competing for the USD 100,000 FFA Award 2025

Future Food Asia announces 10 groundbreaking AgriFoodTech startup finalists competing for the USD 100,000 FFA Award 2025

SINGAPORE, April 28, 2025 /⁨EINPresswire.com⁩/ -- Returning for its 9th edition, Future Food Asia, the premier platform celebrating innovation in AgriFoodtech in APAC, is proud to unveil the 10 startups selected for the finale of its annual competition. …

ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

ElevateBio Announces Presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

– Oral and poster presentations will highlight advancements from ElevateBio’s two business units: Life Edit, its gene editing and R…

VERSES® Announces Closing of US$7.9 Million (C$11.0 Million) Public Offering

VERSES® Announces Closing of US$7.9 Million (C$11.0 Million) Public Offering

VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the "Company”) a cognitive computing company specializing in next-generation intelligent software systems is pleased to announce that the …

Finning to report Q1 2025 results on May 12 and hold investor call on May 13, 2025

Finning to report Q1 2025 results on May 12 and hold investor call on May 13, 2025

VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- Finning International Inc. (TSX: FTT) (“Finning”) will report Q1 2025 results on May 12, 2025 after markets close and hold the investor call on May 13, 2025 at 10:00 AM Eastern Time. To access …

Honeygain Partners with Tipalti to Enhance Global Payout Experience

Honeygain Partners with Tipalti to Enhance Global Payout Experience

Honeygain partners with Tipalti to streamline global payouts, making it easier for users to earn by sharing their internet connection. LONDON, UNITED KINGDOM, April 28, 2025 /⁨EINPresswire.com⁩/ -- Honeygain, the first-ever app that allows its users to …

Volatus Announces $2,000,000 Financing

Volatus Announces $2,000,000 Financing

Not for distribution to United States newswire services or for dissemination in the United States. TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV:FLT) (OTCQX:TAKOF) (Frankfurt: ABB) (“Volatus” or the “Company”) is pleased to …

Volatus annonce un financement de 2 000 000 $

Volatus annonce un financement de 2 000 000 $

Interdiction de diffusion aux agences de presse américaines et de diffusion aux États-Unis. TORONTO, 28 avr. 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV : FLT) (OTCQX : TAKOF) (Francfort : ABB) (« Volatus » ou la « Société ») a le plaisir d' …

leagend Has Launched BA4000 to Lead the Industry

leagend Has Launched BA4000 to Lead the Industry

leagend, a global leader in battery testing and monitoring technologies for over 20 years, releases its invention, battery tester BA4000. SHENZHEN, GUANGDONG, CHINA, April 28, 2025 /⁨EINPresswire.com⁩/ -- leagend releases its battery tester, BA4000, which …

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting

TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting

WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with …

Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025

Cellectis présente une approche non virale d’édition du génome et des innovations avec les base editors à l’ASGCT 2025

NEW YORK, 28 avr. 2025 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS - NASDAQ : CLLS) (la "Société"), société de biotechnologie de stade clinique, qui utilise sa technologie pionnière d'édition de génome pour développer des thérapies cellulaires …

Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion

Tevogen Reaffirms Oncology Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion

Reflects business philosophy of commercial success through patient accessibility Recently executed agreement with CD 8 Technology Services LLC providing up to $50 million for Company’s dedicated R&D and manufacturing facility; no impact on shareholder …

Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

Prolonged duration of response, deep B-cell depletion, and well-tolerated safety profile support the potential of AlloNK® + rituximab for the treatment of B-cell driven diseases in a community setting Additional poster presentation to feature scalability …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service